Posted on by sciencefather
80 / 100
Powered by Rank Math SEO
SEO Score

Mr. Bhoopendra Singh | Nanoformulations | Best Researcher Award

Mr. Bhoopendra Singh, Institute of Pharmacetical Research, GLA UNIVERSITY MATHURA U.P,  India.

Mr. Bhoopendra Singh 🧪 is a Junior Research Assistant at NIPER-Raebareli, specializing in neuropharmacology and drug discovery. With a Master’s in Pharmacy 🎓 and robust skills in HPLC, molecular docking, and ADR analysis, he has authored impactful papers 📚 on Alzheimer’s disease, cancer, and flavonoid pharmacology. Singh’s research is recognized in international conferences 🌍 and indexed journals. His growing academic influence 📈 and technical mastery position him for future breakthroughs in pharmaceutical sciences 💊.

Profile

Orcid 

Google Scholar

🎓 Early Academic Pursuits

Mr. Bhoopendra Singh began his academic journey with a Bachelor of Pharmacy from GLA University, Mathura (2016–2020), achieving a CPI of 7.1/10. He further honed his skills with a Master’s in Pharmacy (2020–2022) at the same institution, where he secured a CPI of 8.5/10. His curriculum covered pharmaceutical formulation, pharmacology, QC/QA, and clinical research, with technical training in experimental pharmacology, molecular docking, and bioinformatics tools—establishing a robust foundation for research in pharmaceutical sciences. 📚🧪

🧑‍🏫 Professional Endeavors

He currently serves as a Junior Research Assistant at NIPER-Raebareli (Dec 2024–Present), contributing to national-level pharmaceutical research. Previously, he worked as an Assistant Professor at B.S.A College of Engineering and Technology (Jan–June 2023), sharing his academic and practical expertise with aspiring students. These roles reflect his progression from academia to industry and highlight his capability in both research and teaching. 🧑‍🔬🏛️

🔬 Contributions and Research Focus On Nanoformulations 

Mr. Bhoopendra Singh’s research contributions focus on neuropharmacology, drug discovery, and molecular modeling, with special emphasis on diseases like Alzheimer’s and diabetic nephropathy. His work explores therapeutic potentials of bioactive compounds, including ascorbic acid, hordenine, and casticin, through both experimental and computational approaches. He has published several peer-reviewed articles in reputed journals, showcasing his expertise in pharmacokinetics, toxicology, and pharmacodynamics. With experience in techniques like molecular docking, MTT assay, and HPLC, he blends laboratory precision with data-driven analysis. His commitment to addressing complex health conditions through innovative pharmaceutical research highlights his role as a valuable contributor to biomedical science.

🏅 Accolades and Recognition

Mr. Bhoopendra Singh has garnered significant accolades and recognition for his contributions to pharmaceutical research. His scholarly work has led to multiple publications in reputed journals such as Current Pharmaceutical Biotechnology, Current Molecular Medicine, and Ageing Research Reviews. He has presented at prestigious conferences, including the International Conference on Innovations in Chemical, Biological, and Pharmaceutical Sciences. Notably, his research on Alzheimer’s disease and anticancer compounds has earned commendations from peers and mentors alike. His Research Interest Score of 7.2, h-index of 3, and growing citation count reflect

Mr. Bhoopendra Singh possesses strong research skills grounded in pharmacology and pharmaceutical sciences. He is adept at conducting experimental pharmacology, drug-receptor interaction studies, and both preclinical and clinical research. His technical proficiency includes using MTT and Alamar Blue assays, HPLC, molecular docking, and bioinformatics tools such as BioRender and statistical software like R and SAS. He is skilled in literature mining using EndNote and Mendeley and has experience in pharmacovigilance and adverse drug reaction monitoring. His ability to integrate theoretical knowledge with practical applications enables him to contribute meaningfully to drug discovery and therapeutic research initiatives.

Bhoopendra Singh | Nanoformulations | Best Researcher Award

You May Also Like